{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:25:54Z","timestamp":1793514354917,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bioorg.2025.108694","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:50:22Z","timestamp":1750420222000},"page":"108694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase\u2011carbonic anhydrase inhibitors with potential anti-tubulin activity"],"prefix":"10.1016","volume":"163","author":[{"given":"Mamdouh F.A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.A.","family":"Fadaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T.M.","family":"Nemr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Ewieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrous A.","family":"Abou-Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bioorg.2025.108694_bb0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of Cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"10352","key":"10.1016\/j.bioorg.2025.108694_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the global burden of disease study 2019","volume":"400","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05948","article-title":"Drug combination and repurposing for cancer therapy: the example of breast cancer","volume":"7","author":"Correia","year":"2021","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108694_bb0020","first-page":"2370","article-title":"Study on the Socio-Economic Impact of Cancer Disease on Cancer Patients and their Relatives","volume":"vol. 10","author":"Garcia Martin","year":"2022","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.108694_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112904","article-title":"Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors","volume":"209","author":"Bass","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.05.034","article-title":"Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents","volume":"155","author":"Peerzada","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108694_bb0035","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.3390\/molecules27154948","article-title":"Hybrid molecules containing naphthoquinone and Quinolinedione scaffolds as antineoplastic agents","volume":"27","author":"Mancini","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108694_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25051047","article-title":"Antimicrobial, antioxidant, and anticancer activities of some novel Isoxazole ring containing Chalcone and Dihydropyrazole derivatives","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108694_bb0045","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.108694_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107498","article-title":"Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives","volume":"149","author":"Yang","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108694_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bioorg.2017.03.005","article-title":"Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors","volume":"72","author":"Mohamed","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110297","article-title":"Chalcones: promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer","volume":"369","author":"WalyEldeen","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108694_bb0070","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/01480545.2018.1463242","article-title":"The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity","volume":"42","author":"Aslan","year":"2019","journal-title":"Drug Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bmc.2018.10.045","article-title":"Design, synthesis and QSAR study of 2\u2032-hydroxy-4\u2032-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway","volume":"27","author":"Marquina","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0080","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2147\/DDDT.S256756","article-title":"Novel HDAC\/tubulin dual inhibitor: design, synthesis and docking studies of \u03b1-phthalimido-chalcone hybrids as potential anticancer agents with apoptosis-inducing activity","author":"Mourad","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14756366.2022.2056734","article-title":"Novel 3-(6-methylpyridin-2-yl) coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0090","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","article-title":"Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2 (3H)-benzoxazolones","volume":"34","author":"Bilginer","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2019.05.013","article-title":"New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity","volume":"176","author":"Casta\u00f1o","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107089","article-title":"Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: design, synthesis and anti-proliferative activity","volume":"144","author":"Higazy","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106621","article-title":"Substituted furan sulfonamides as carbonic anhydrase inhibitors: synthesis, biological and in silico studies","volume":"138","author":"Angeli","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107096","article-title":"Novel 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide based thiosemicarbazides as potent and selective inhibitors of tumor-associated human carbonic anhydrase IX and XII: synthesis, cytotoxicity, and molecular modelling studies","volume":"144","author":"Demir-Yaz\u0131c\u0131","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108694_bb0115","first-page":"5289","article-title":"Sulfonamides: synthesis and the recent applications in medicinal chemistry","volume":"63","author":"El-Gaby","year":"2020","journal-title":"Egypt. J. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70135","article-title":"Design, synthesis, and in vitro evaluation of aromatic sulfonamides as human carbonic anhydrase I, II, IX, and XII inhibitors and their antioxidant activity","volume":"39","author":"Abha Mishra","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"32","key":"10.1016\/j.bioorg.2025.108694_bb0125","doi-asserted-by":"crossref","first-page":"23257","DOI":"10.1039\/D4RA04548C","article-title":"Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1, 4-dioxides as carbonic anhydrase inhibitors","volume":"14","author":"Buravchenko","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108694_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103839","article-title":"Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1, 2, 3-triazole chalcone hybrids","volume":"99","author":"Singh","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.108694_bb0135","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides","volume":"26","author":"Arslan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108694_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112158","article-title":"Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response","volume":"192","author":"Wu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/br.2024.1884","article-title":"Design, synthesis, biological and in silico evaluation of 3-carboxy-coumarin sulfonamides as potential antiproliferative agents targeting HDAC6","volume":"22","author":"Madrigal-Angulo","year":"2024","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.bioorg.2025.108694_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104439","article-title":"Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS\/PGE2 inhibitors","volume":"105","author":"Mohamed","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108694_bb0155","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/ph14111177","article-title":"Design, synthesis, in vitro anticancer evaluation and molecular modelling studies of 3,4,5-Trimethoxyphenyl-based derivatives as dual EGFR\/HDAC hybrid inhibitors","volume":"14","author":"Ibrahim","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108694_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104885","article-title":"Novel 1,2,4-oxadiazole-chalcone\/oxime hybrids as potential antibacterial DNA gyrase inhibitors: design, synthesis, ADMET prediction and molecular docking study","volume":"111","author":"Ibrahim","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108694_bb0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108694_bb0175","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bioorg.2018.07.027","article-title":"Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"80","author":"Abdel-Aziz","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/14756366.2020.1722121","article-title":"Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors","volume":"35","author":"El-Azab","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0185","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2147\/DDDT.S256756","article-title":"Novel HDAC\/tubulin dual inhibitor: design, synthesis and docking studies of alpha-phthalimido-chalcone hybrids as potential anticancer agents with apoptosis-inducing activity","volume":"14","author":"Mourad","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bioorg.2025.108694_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.09.063","article-title":"Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues","volume":"141","author":"Mustafa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejmech.2017.11.055","article-title":"A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: design, synthesis, molecular modelling, and biological evaluation","volume":"143","author":"Naret","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2025.108694_bb0200","first-page":"E7405","article-title":"Metal-mediated diradical tuning for DNA replication arrest via template strand scission","volume":"114","author":"Porter","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.108694_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110571","article-title":"Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate\u20134-thiazolinone hybrid derivatives","volume":"131","author":"Ramadan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108694_bb0210","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0215","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/146282","article-title":"Targeting the Mitotic Catastrophe Signaling Pathway in Cancer","volume":"2015","author":"Mc Gee","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bioorg.2025.108694_bb0220","article-title":"Promoting apoptosis, a promising way to treat breast Cancer with natural products: a comprehensive review","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0230","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41598-023-30436-y","article-title":"Biogenic copper oxide nanoparticles from Bacillus coagulans induced reactive oxygen species generation and apoptotic and anti-metastatic activities in breast cancer cells","volume":"13","author":"Dolati","year":"2023","journal-title":"Sci. Rep."},{"issue":"52","key":"10.1016\/j.bioorg.2025.108694_bb0235","doi-asserted-by":"crossref","first-page":"40525","DOI":"10.1074\/jbc.M110.167635","article-title":"Activation of caspase-9, but not caspase-2 or caspase-8, is essential for heat-induced apoptosis in Jurkat cells","volume":"285","author":"Shelton","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108694_bb0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/C8CC07813K","article-title":"Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule","volume":"55","author":"Zhao","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.108694_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115860","article-title":"PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-\u03b2 in chromatin of breast cancer cells","volume":"436","author":"Sethy","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"37","key":"10.1016\/j.bioorg.2025.108694_bb0255","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108694_bb0260","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6979","key":"10.1016\/j.bioorg.2025.108694_bb0265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108694_bb0270","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108694_bb0275","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bmcl.2007.12.031","article-title":"Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1\/HDAC2 inhibitors (SHI-1: 2)","volume":"18","author":"Methot","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108694_bb0280","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/j.tet.2010.01.061","article-title":"Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors","volume":"66","author":"Terracciano","year":"2010","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13568-025-01835-3","article-title":"Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa","volume":"15","author":"Alyahyawy","year":"2025","journal-title":"AMB Express"},{"issue":"W1","key":"10.1016\/j.bioorg.2025.108694_bb0290","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2025.108694_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107727","article-title":"Novel anti-inflammatory agents featuring phenoxy acetic acid moiety as a pharmacophore for selective COX-2 inhibitors: synthesis, biological evaluation, histopathological examination and molecular modeling investigation","volume":"152","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106649","article-title":"Targeting the hedgehog pathway with novel Gli1 hydrophobic tagging degraders","volume":"138","author":"Li","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108694_bb0305","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cmdc.201700001","article-title":"Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization","volume":"12","author":"Qiu","year":"2017","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108694_bb0310","doi-asserted-by":"crossref","first-page":"2358934","DOI":"10.1080\/14756366.2024.2358934","article-title":"Novel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors","volume":"39","author":"Mahnashi","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108694_bb0315","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1021\/acs.jmedchem.9b00946","article-title":"Discovery of a new Isoxazole-3-hydroxamate-based histone deacetylase 6 inhibitor SS-208 with antitumor activity in syngeneic melanoma mouse models","volume":"62","author":"Shen","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108694_bb0320","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4155\/fmc-2019-0290","article-title":"Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells","volume":"12","author":"Zhang","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2019.03.052","article-title":"Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives","volume":"87","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108694_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082161","article-title":"A new inhibitor of tubulin polymerization kills multiple Cancer cell types and reveals p21-mediated mechanism determining cell death after mitotic catastrophe","volume":"12","author":"Zdioruk","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108694_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105564","article-title":"Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase\/HDAC inhibitors","volume":"119","author":"Bass","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108694_bb0340","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/ph13070152","article-title":"Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells","volume":"13","author":"Md","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bioorg.2025.108694_bb0345","doi-asserted-by":"crossref","first-page":"108181","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo [3, 4-d] pyrimidine\/1, 2, 4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: design, synthesis, in silico and in vivo studies","volume":"156","author":"Aziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108694_bb0350","article-title":"Microwave assisted synthesis, biological assessment and in-silico studies of some new 5, 5\u2032-(phenylmethylene) bisuracil and dihydropyrido [2, 3-d, 6, 5-d\u2019] dipyrimidine derivatives as selective COX-2 inhibitors with potential anti-inflammatory activities","volume":"141504","author":"Hayallah","year":"2025","journal-title":"J. Mol. Struct."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825005747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:56:20Z","timestamp":1776920180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825005747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":70,"alternative-id":["S0045206825005747"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108694","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase\u2011carbonic anhydrase inhibitors with potential anti-tubulin activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108694"}}